Latest "Esanex" News Stories

07:02 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Esanex" found in our extensive news archives from over 250 global news sources.

More Information about Esanex on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Esanex for you to read. Along with our medical data and news we also list Esanex Clinical Trials, which are updated daily. BioPortfolio also has a large database of Esanex Companies for you to search.

Showing "Esanex" News Articles, all 1


Esanex Announces Successful End-of-Phase 2 Meeting for SNX-5422 in Neuroendocrine Tumors

-- Agreement reached with FDA on key elements of Phase 3 trial – -- SNX-5422 Granted Orphan Drug Designation -- Esanex, Inc., a clinical stage company developing Heat Shock Protein inhibitors for the treatment of cancer, today announced the successful conclusion of

Quick Search


News Quicklinks